CM
BPMC

Caption Management’s Blueprint Medicines BPMC Stock Holding History

Caption Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-91,100
Closed -$11.7M – 1688
2025
Q2 		$11.7M Buy
+91,100
New +$9.46M 0.13% 169
2024
Q4 		– Sell
-13,500
Closed -$1.25M – 1473
2024
Q3 		$1.25M Buy
+13,500
New +$1.34M 0.02% 711
2024
Q2 		– Sell
-25,000
Closed -$2.37M – 1175
2024
Q1 		$2.37M Sell
25,000
-5,800
-19% -$497K 0.04% 489
2023
Q4 		$2.84M Buy
30,800
+5,800
+23% +$376K 0.04% 511
2023
Q3 		$1.26M Buy
+25,000
New +$1.34M 0.02% 707
2022
Q3 		– Sell
-25,000
Closed -$1.26M – 1510
2022
Q2 		$1.26M Buy
+25,000
New +$1.46M 0.02% 796
2022
Q1 		– Sell
-25,000
Closed -$2.68M – 1482
2021
Q4 		$2.68M Sell
25,000
-5,000
-17% -$523K 0.03% 684
2021
Q3 		$3.08M Buy
+30,000
New +$2.79M 0.04% 607
2019
Q4 		– Sell
-90,000
Closed -$6.61M – 831
2019
Q3 		$6.61M Buy
90,000
+55,400
+160% +$4.79M 0.34% 72
2019
Q2 		$3.26M Buy
+34,600
New +$2.86M 0.16% 173

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's BPMC Position: Q2 2025 in Review

Caption Management sold out of Blueprint Medicines (BPMC) in Q2 2025, closing a stake of 7,000 shares — an estimated $727K sold.

Caption Management first reported a position in BPMC in Q1 2019 and held it in 7 quarters. The position peaked at $3.67M in Q3 2019. 354 funds tracked by Wall St. Rank hold BPMC as of Q2 2025.

  • Caption Management reported no remaining Blueprint Medicines position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 7,000 Blueprint Medicines shares in Q2 2025, an estimated $727K.
  • Caption Management first reported a position in Blueprint Medicines in Q1 2019 and held it in 7 quarters.
  • Caption Management's Blueprint Medicines position peaked at $3.67M in Q3 2019.
  • 354 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.